2025年新墨西哥州麻疹疫情应对
2025年1月西德克萨斯社区暴发大规模麻疹疫情并扩散至新墨西哥州,新墨西哥州卫生部最终报告99例相关病例,约半数发生于成人。该部门实施集中网页、电话热线和移动接种门诊等多模式沟通与接种外展策略,同期全州MMR疫苗接种剂次较2024年同期增加55%。协调公共沟通与改善MMR疫苗可及性可支持大范围农村地区的接种实施并助力疫情应对。
要点
- 2025年新墨西哥州报告99例麻疹暴发相关病例,约半数发生在成人。
- 多模式沟通与外展策略期间,全州MMR接种剂次同比增加55%。
- 协调公共沟通和改善疫苗可及性有助于农村地区疫情应对。
核心结论
- 协调公共沟通与改善MMR疫苗可及性可支持大范围农村地区接种实施,并有助于麻疹暴发应对。
研究设计与样本
- 描述2025年新墨西哥州麻疹暴发及州卫生部实施的多模式沟通与接种外展策略,并比较2025年1月1日至9月26日与2024年同期全州MMR接种剂次。
主要发现
- 新墨西哥州卫生部最终报告99例暴发相关麻疹病例,约半数发生于成人。
- 外展策略包括集中网页、电话热线和移动接种门诊。
- 外展策略期间全州MMR疫苗接种剂次较2024年同期增加55%。
关键数值与推荐
- 接种2剂麻疹疫苗预防疾病的效力为97%,推荐所有≥12月龄人群接种。
临床怎么用
- 在大型农村地区协调公共信息发布并改善MMR疫苗可及性,可支持麻疹暴发应对中的接种实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Measles is a highly contagious respiratory virus with the potential to cause large outbreaks, as well as serious complications, hospitalization, and death. Receipt of 2 doses of measles vaccine is 97% effective at preventing disease and is recommended for all persons aged ≥12 months to ensure high levels of population immunity and reduce the risk for outbreaks. In January 2025, a large measles outbreak began in a west Texas community and quickly spread to nearby jurisdictions, including New Mexico. The New Mexico Department of Health (NMDOH) eventually reported 99 outbreak-related measles cases, approximately one half of which occurred in adults. To facilitate dissemination of information and distribution of resources across a geographically large, rural state, NMDOH implemented a multimodal communication and vaccination outreach strategy, including a centralized webpage, a telephone helpline, and mobile vaccination clinics. The outreach strategy coincided with a statewide 55% increase in MMR vaccine doses administered during January 1-September 26, 2025, compared with the same period in 2024. Coordinating public communication and improving access to MMR vaccine can support vaccine administration across large, rural areas and contribute to a measles outbreak response.
引用
- Stanislawski E, Romero A, Holzinger N, et al. Measles Outbreak - New Mexico, 2025. MMWR Morb Mortal Wkly Rep. 2026. PMID: 41818136. doi:10.15585/mmwr.mm7509a1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。